Shanghai Jeyou Pharmaceutical Co., Ltd.
↗Shanghai, China (Pudong district)
Shanghai Jeyou Pharmaceutical Co., Ltd., originally the R&D center of Jiangxi Jemincare Group Co., Ltd., has been spun off as an independent entity. The company has built a strong scientific team with comprehensive end-to-end capabilities in drug discovery and development. Jeyou focuses on oncology, nephrology, cerebro-cardiovascular, analgesic, respiratory health, and immunology therapeutics. The company has progressed more than 10 programs to the clinical stage from its in-house pipeline and is actively advancing multiple drug candidates through clinical development.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Innovative Drug Development
SIZE & FINANCIALS
Employees:201-500
Founded:1999
Ownership:private
Status:operating
FUNDING
Stage:Growth Stage
Total Raised:$143.0M
Investors:Select group of accredited investors (December 2024 private placement)
PIPELINE
Stage:Preclinical to Phase 2
Lead Drug Stage:Phase 2
Modalities:Small molecule, Monoclonal antibody, Biotherapeutics
Active Trials:2
Trial Phases:Phase 2: 2
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Jiangxi Jemincare Group Co., Ltd. (spinoff entity)
Key Partnerships:RAPT Therapeutics - RPT904 (JYB1904) development in chronic spontaneous urticaria and asthma; $35M upfront + up to $672.5M milestones (December 2024)
COMPETITION
Position:Emerging
Competitors:Harbour BioMed, VelaVigo, CStone Pharmaceuticals, JW Therapeutics, I-Mab, Jiangsu Hengrui Pharmaceuticals, Other Chinese biotech in oncology/immunology
LEADERSHIP
Key Executives:
Ting Li - President
LINKS
Website:jeyoupharma.com
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Shanghai Jeyou Pharmaceutical Co., Ltd.. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.